Casgevy, a groundbreaking treatment approved to treat sickle cell disease in December, has now been approved to treat another inherited blood disorder.
The US Food and Drug Administration has approved a second use for the first CRISPR-based medicine, Casgevy, which was approved in December to treat sickle cell disease.
FDA approves exagamglogene autotemcel to treat beta-thalassemia medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
FDA clears first CRISPR treatment for a second disease, beta thalassemia kdrv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kdrv.com Daily Mail and Mail on Sunday newspapers.
FDA Roundup: January 16, 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.